Incidence and Risk Factors Associated With 30-Day Readmission for Alcoholic Hepatitis
Sushil Kumar Garg(Chandigarh University), Michael D. Leise(Mayo Clinic in Arizona), Itegbemie Obaitan(University of Minnesota), Sumeet K. Asrani(Baylor University Medical Center), Vijay H. Shah(Mayo Clinic in Arizona), Thoetchai Peeraphatdit(Baylor University Medical Center), Loretta Jophlin(University of Louisville), Dupinder Singh(University of Minnesota), Shashank Sarvepalli(Cleveland Clinic)
Cited by 14
Related Papers
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
|Gastroenterology|2021|583
MELD accurately predicts mortality in patients with alcoholic hepatitis†
|Hepatology|2005|530
Underestimation of Liver-Related Mortality in the United States
|Gastroenterology|2013|309
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates
|Gastroenterology|2008|306
ACG Clinical Guideline: Alcohol-Associated Liver Disease
|The American Journal of Gastroenterology|2023|227